Delek US Holdings, Inc. (NYSE:DK) Stock Has Average Target Price of $77.75

Delek US Holdings, Inc. (NYSE:DK) has been assigned an average recommendation of “Moderate Buy” from the fourteen brokerages that are currently covering the firm, MarketBeat.com reports. Seven analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $77.50.

A number of research firms have recently commented on DK. Morgan Stanley increased their price objective on Delek US from $45.00 to $81.00 and gave the company an “equal weight” rating in a report on Monday, September 14th. Wall Street Zen upgraded Delek US from a “buy” rating to a “strong-buy” rating in a research note on Sunday, August 9th. Piper Sandler began coverage on Delek US in a research note on Tuesday, October 27th. They set a “neutral” rating and a $90.00 target price for the company. Raymond James Financial reaffirmed an “outperform” rating and issued a $95.00 price target on shares of Delek US in a report on Friday, November 6th. Finally, Wells Fargo & Company increased their price target on shares of Delek US from $82.00 to $95.00 and gave the company an “overweight” rating in a research note on Wednesday, October 14th.

Delek US Stock Up 0.2%

NYSE DK traded up $0.16 on Thursday, hitting $68.57. 823,148 shares of the stock were exchanged, compared to its average volume of 1,585,088. The company has a quick ratio of 0.92, a current ratio of 1.33 and a debt-to-equity ratio of 2.03. Delek US has a fifty-two week low of $25.85 and a fifty-two week high of $82.27. The company has a market cap of $4.16 billion, a PE ratio of 3.64, a PEG ratio of 0.46 and a beta of 0.61. The company has a 50-day moving average price of $73.06 and a 200-day moving average price of $54.71.

Delek US (NYSE:DK) last announced its quarterly earnings data on Friday, November 6th. The oil and gas company reported $13.55 earnings per share for the quarter, beating analysts’ consensus estimates of $8.05 by $5.50. The business had revenue of $4.39 billion for the quarter, compared to analyst estimates of $3.88 billion. Delek US had a net margin of 8.70% and a return on equity of 140.39%. The company’s revenue was up 52.1% on a year-over-year basis. During the same period last year, the business earned $7.13 EPS. Sell-side analysts anticipate that Delek US will post 20.15 EPS for the current fiscal year.

Delek US Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, November 18th. Investors of record on Tuesday, November 10th will be given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.8%. This is a boost from Delek US’s previous quarterly dividend of $0.2550. The ex-dividend date of this dividend is Tuesday, November 10th. Delek US’s dividend payout ratio is presently 6.37%.

Insider Buying and Selling

In other Delek US news, Director Vicky Sutil sold 6,397 shares of the firm’s stock in a transaction dated Friday, September 4th. The stock was sold at an average price of $71.50, for a total transaction of $457,385.50. Following the transaction, the director owned 26,407 shares of the company’s stock, valued at approximately $1,888,100.50. This trade represents a 19.50% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Sullivan, Jr. sold 27,688 shares of Delek US stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $69.01, for a total value of $1,910,748.88. Following the sale, the director owned 32,004 shares in the company, valued at $2,208,596.04. This trade represents a 46.38% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 163,377 shares of company stock valued at $11,082,485 over the last ninety days. Company insiders own 3.56% of the company’s stock.

Institutional Investors Weigh In On Delek US

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Empowered Funds LLC boosted its holdings in shares of Delek US by 1,262.6% in the third quarter. Empowered Funds LLC now owns 140,345 shares of the oil and gas company’s stock valued at $10,016,000 after acquiring an additional 130,045 shares during the period. Bleakley Financial Group LLC purchased a new position in shares of Delek US during the third quarter worth approximately $2,447,000. First Trust Advisors LP grew its position in shares of Delek US by 88.2% during the third quarter. First Trust Advisors LP now owns 100,543 shares of the oil and gas company’s stock worth $7,176,000 after acquiring an additional 47,119 shares during the last quarter. Advisors Asset Management Inc. purchased a new position in shares of Delek US during the third quarter worth approximately $1,516,000. Finally, Ieq Capital LLC purchased a new position in shares of Delek US during the third quarter worth approximately $607,000. Hedge funds and other institutional investors own 97.01% of the company’s stock.

About Delek US

Delek US Holdings, Inc. is an independent downstream energy company focused on petroleum refining and related logistics in the southern United States. Its refining operations are located in Texas, Arkansas and Louisiana, where it processes crude oil into transportation fuels and other petroleum products. Products from Delek US refineries include gasoline, diesel, jet fuel, asphalt and petroleum coke. The company also markets refined products to customers and operates midstream assets, including pipelines, terminals and storage facilities, through its subsidiary Delek Logistics Partners.